Back
Regions Financial Vs. Corcept Therapeutics Industry Stock Comparison
Buy
80
RF
Regions Financial
Last Price:
$22.26
Seasonality Move:
0.76%
Buy
67
CORT
Corcept Therapeutics
Last Price:
$72.21
Seasonality Move:
10.06%
Buy
80
Regions Financial (RF)
is a Buy
Is Regions Financial a Buy, Sell or Hold?
-
The current Regions Financial [RF] share price is $22.25. The Score for RF is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
RF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $72.14. The Score for CORT is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RF Stock Price Chart
What is Regions Financial's stock price today?
-
The Regions Financial share price today is $22.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RF is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $72.14Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
RF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 65.59 | Buy |
| Chaikin Money Flow: | 2633847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.15 - 21.03) | Buy |
| Bollinger Bands (100): | (20.62 - 24.38) | Sell |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.33 | Buy |
| Relative Strength Index (14 RSI): | 53.36 | Buy |
| Chaikin Money Flow: | 460045 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.64 - 73.18) | Buy |
| Bollinger Bands (100): | (52.96 - 73.02) | Buy |
RF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.11 | Buy |
| 20-day SMA: | 20.36 | Buy |
| 50-day SMA: | 20.88 | Buy |
| 200-day SMA: | 23.02 | Sell |
| 8-day EMA: | 21.18 | Buy |
| 20-day EMA: | 20.74 | Buy |
| 50-day EMA: | 21.14 | Buy |
| 200-day EMA: | 22.11 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.64 | Buy |
| 20-day SMA: | 69.67 | Buy |
| 50-day SMA: | 66.57 | Buy |
| 200-day SMA: | 53.74 | Buy |
| 8-day EMA: | 71.32 | Buy |
| 20-day EMA: | 69.15 | Buy |
| 50-day EMA: | 54.49 | Buy |
| 200-day EMA: | 21.72 | Buy |
Regions Financial Earnings Growth & RF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.04 per share, an increase this year of $0.14 per share, and an increase next year of $0.20 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.03 per share, and an increase next year of $1.28 per share.
Regions Financial Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||